Aktienanalyse zu Pro-Dex Inc (PDEX)PDEXPro-Dex Inc

Pro-Dex, Inc. specializes in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and maxocranial facial markets. The Company has patented adoptive torque-limiting software and sealing solutions, which appeal to its customers, primarily medical device distributors. It also manufactures and sells rotary air motors to a range of industries. The Company’s medical device products utilize designs developed by it primarily under development and supply agreements and are machined in its Irvine, California facility, and assembled in its Tustin, California facility, as are its rotary air motors. Its medical device products are sold primarily to original equipment manufacturers and its air motors are sold primarily to a range of distributors and end users. It manufactures machined sub-assemblies and also produces parts and assemblies for aerospace and defense systems. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).

Pro-Dex Inc is currently not a strong buy due to its recent price decline and low RSI, but it shows potential for recovery in the long term. The current price is $62.55, with a 5-day change of -4.74%, indicating short-term weakness. However, the year-to-date change of +65.84% suggests strong long-term performance. The forward P/E ratio of 22.83 indicates that the stock may be overvalued at this price point, and the RSI of 30.09 suggests it is oversold, which could lead to a rebound. The main risk is the recent decline in revenue growth, with Q2 revenue at $18.66 million, which is lower than expected, impacting investor sentiment.

1 analysts cover PDEX: 1 rate it Buy, 0 Hold and 0 Sell.